The PROMISE II Trial, Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (PROMISE)
Conditions
Diseases of the Cardiovascular System
Volunteers
Health Professionals
What is the purpose of this trial?
The LimFlow System is intended for endovascular, minimally invasive procedures in patients who have a clinical diagnosis of chronic limb-threatening ischemia and who have been determined to have no surgical or endovascular treatment option (i.e., "no option").
- Ages18 years - 95 years
- GenderBoth
- Trial withLimFlow SA
- Start Date09/03/2020
- End Date08/30/2022
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigators
- Last Updated04/20/2022
- Study HIC#2000027620